| Net Cash Provided by (Used in) Operating Activities |
$74,801 |
USD |
-3022% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$204,858 |
USD |
8497% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
75,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
19,767,698 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$130,285 |
USD |
|
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$130 |
USD |
12929% |
Q3 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$13 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$1,010,200 |
USD |
-0.38% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$1,010,200 |
USD |
-0.38% |
Q2 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$874,906 |
USD |
-18809% |
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
$2,782,203 |
USD |
4.8% |
Q3 2025 |
Q1 2026 |
| Amortization of Intangible Assets |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q2 2025 |
FY 2025 |